Atara Biotherapeutics, Inc. short interest in 2023
In 2023, Atara Biotherapeutics, Inc.'s disclosed short interest ran from 14.36% of shares outstanding on 13 Jan 2023 to 9.01% on 29 Dec 2023, a change of -5.35 percentage points. The year's high was 20.81% on 31 Mar 2023 and its low 8.01% on 15 Nov 2023, averaging 13.45% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.79 days on 28 Feb 2023. Full history: Atara Biotherapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 14.36% (13 Jan 2023)
- End of year
- 9.01% (29 Dec 2023)
- Change
- -5.35 pp
- High
- 20.81% (31 Mar 2023)
- Low
- 8.01% (15 Nov 2023)
- Average
- 13.45%
- Highest days to cover
- 19.79 (28 Feb 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 14.36% | 11.92 | |
| 31 Jan 2023 | 14.79% | 13.58 | |
| 15 Feb 2023 | 14.60% | 14.44 | 10-K filed, results (8-K) |
| 28 Feb 2023 | 14.67% | 19.79 | |
| 15 Mar 2023 | 17.41% | 11.50 | |
| 31 Mar 2023 | 20.81% | 13.32 | |
| 14 Apr 2023 | 20.03% | 16.28 | |
| 28 Apr 2023 | 18.55% | 14.00 | |
| 15 May 2023 | 14.47% | 7.81 | 10-Q filed, results (8-K) |
| 31 May 2023 | 12.88% | 6.43 | |
| 15 Jun 2023 | 13.48% | 5.74 | |
| 30 Jun 2023 | 11.94% | 4.03 | |
| 14 Jul 2023 | 12.88% | 9.39 | |
| 31 Jul 2023 | 13.22% | 12.41 | |
| 15 Aug 2023 | 12.06% | 9.52 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 11.40% | 8.98 | |
| 15 Sep 2023 | 11.54% | 17.39 | |
| 29 Sep 2023 | 11.41% | 8.65 | |
| 13 Oct 2023 | 12.14% | 9.24 | |
| 31 Oct 2023 | 12.25% | 12.30 | |
| 15 Nov 2023 | 8.01% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 10.90% | 1.54 | |
| 15 Dec 2023 | 9.94% | 4.24 | |
| 29 Dec 2023 | 9.01% | 1.85 |
See also: Atara Biotherapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.